Diaphragmatic Physiology Similarity Index May Titrate HFNC Flow Setting: A Prospective Observational Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSir Run Run Shaw Hospital

About this trial

Study Objective This prospective observational study aims to investigate the role of the Diaphragmatic Physiology Similarity Index (DPSI) derived from speckle tracking ultrasound in titrating high-flow nasal cannula (HFNC) flow settings, and to evaluate its application in patients with acute respiratory failure.

Primary Research Questions

To characterize the features of the DPSI in healthy individuals and in patients with acute respiratory failure.

To assess the behavior of the DPSI under different HFNC flow settings in patients with acute respiratory failure.

Secondary Research Questions

Feasibility and inter-operator reproducibility of diaphragmatic speckle tracking.

Assessment of the Diaphragmatic Contraction Synchrony Index.

Evaluation of End-Diaphragmatic Residual Contraction (EDRC).

Additional fundamental parameters, including diaphragmatic displacement velocity and maximum displacement.

Eligibility criteria

Qualifiers

Age ≥18 years old.

Clear diagnosis of respiratory failure requiring respiratory support.

Expected duration of respiratory support ≥24 hours or (high-flow/non-invasive ventilation) ≥48 hours.

Voluntary participation in this study and signed informed consent. If the participant is unable to read or sign the informed consent form due to incapacity (e.g., unconsciousness), the legal guardian must act as a proxy in the informed consent process and sign the form. If the participant cannot read the consent form (e.g., illiterate participants), a witness must observe the informed consent process and sign the form.

Disqualifiers

Severe chest wall deformities or diaphragmatic paralysis.

End-stage disease with a predicted life expectancy of less than 24 hours.

Inability to acquire STE (strains and echoes) images (e.g., severe subcutaneous emphysema, position limitations).

Vulnerable groups other than critically ill patients/elderly/illiterate individuals, including those with mental disorders, cognitive impairments, pregnant women, etc.

Trial design

Treatments tested in this trial

  • High-flow adjustment sequence

Treatment groups

100 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators